@article{article_1333370, title={Hepatotoxicity case due to interferon beta-1a use}, journal={Akademik Gastroenteroloji Dergisi}, volume={22}, pages={164–167}, year={2023}, DOI={10.17941/agd.1333370}, author={Yolaçan, Ramazan and Kaya, Bekir and Karabulut, Ümit and Üzel, Ali and Uçmak, Feyzullah and Kaya, Muhsin}, keywords={Multipl skleroz, karaciğer fonksiyon bozukluğu, interferon β}, abstract={Interferon β-1a is an immunomodulatory drug widely used in the treatment of multiple sclerosis. Liver dysfunction is a common side effect of this drug and usually develops within the first 6 months of starting interferon therapy. Here, we present our case who developed hepatotoxicity secondary to interferon β-1a treatment.}, number={3}, publisher={Türk Gastroenteroloji Vakfı}